Stay updated on Dapagliflozin in Acute Heart Failure Clinical Trial

Sign up to get notified when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Dapagliflozin in Acute Heart Failure Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    2 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:45:24.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value 7 has recently changed to 8 on the webpage, indicating a potential update in a medical and healthcare-related publication or documentation regarding the effect of in-hospital initiation of dapagliflozin versus placebo on the clinical outcome of cardiovascular death or worsening heart failure in patients stabilized during hospitalization for acute heart failure.
    Difference
    0.1%
    Check dated 2024-06-06T14:39:26.000Z thumbnail image
  7. Check
    24 days ago
    Change Detected
    Summary
    The 'Participation Criteria' section has been updated to provide detailed eligibility criteria for participants, including age, health conditions, and prior treatments, replacing the previous placeholder text that indicated no information was provided.
    Difference
    44%
    Check dated 2024-05-22T21:30:14.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    1%
    Check dated 2024-04-30T22:51:43.000Z thumbnail image

Stay in the know with updates to Dapagliflozin in Acute Heart Failure Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.